In clinical trials the new oral anticoagulants (NOACs) have been shown to have similar efficacy and safety compared to warfarin, but questions have been raised about whether the results are similar in real world settings. Now a new observational study lends some measure of reassurance that the new drugs are not associated with increased bleeding ...
NOACs not linked to excess bleed rates
By Larry Husten
20 Oct 2017